{
  "paper_metadata": {
    "pmid": "37788558",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant p.Val30Met, including penetrance data and patient demographics."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "65 year-old Caucasian male, 63 year-old Caucasian male",
        "phenotype": "Transthyretin Cardiac Amyloidosis (ATTR-CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with transthyretin cardiac amyloidosis",
          "evidence_sentence": "Here, we described the generation of two iPSC lines derived from a 65 year-old Caucasian male patient (SCVIi066-A) diagnosed with transthyretin cardiac amyloidosis due to a heterozygous mutation in the TTR gene (c.148G>A encoding p.Val30Met; pathogenic variant)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 63,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with transthyretin cardiac amyloidosis",
          "evidence_sentence": "Here, we described the generation of two iPSC lines derived from a 63 year-old Caucasian male patient (SCVIi067-A) diagnosed with transthyretin cardiac amyloidosis due to a heterozygous mutation in the TTR gene (c.148G>A encoding p.Val30Met; pathogenic variant)."
        }
      ],
      "functional_data": {
        "summary": "The iPSC lines showed expression of high levels of pluripotency markers and normal karyotype.",
        "assays": [
          "Sanger sequencing",
          "RT-qPCR",
          "immunofluorescence staining"
        ]
      },
      "segregation_data": "The mutation segregates with disease in the two patients described.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Main Text, Abstract and Resource details",
      "additional_notes": "The Val30Met mutation is one of the most common mutations in the TTR gene.",
      "key_quotes": [
        "The mutation Val30Met (also known as V50M) is one of the most common mutations in the TTR gene and is endemic in some countries (e.g., Portugal and Sweden)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}